(VIANEWS) - Cyclacel Pharmaceuticals (CYCCP), Blackrock Health Sciences Trust (BME), Autohome (ATHM) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Cyclacel Pharmaceuticals (CYCCP) | 7.56 | 1.45% | 9.68% | 2022-01-25 07:23:13 |
| 2 | Blackrock Health Sciences Trust (BME) | 45.05 | 0.56% | 5.67% | 2022-02-05 01:08:07 |
| 3 | Autohome (ATHM) | 30.57 | 0.39% | 2.85% | 2022-02-04 19:15:09 |
| 4 | Intel (INTC) | 48.01 | 0.2% | 2.75% | 2022-02-04 16:12:20 |
| 5 | Fidelity D & D Bancorp (FDBC) | 51.04 | -0.89% | 2.56% | 2022-01-31 13:13:05 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Cyclacel Pharmaceuticals (CYCCP) - Dividend Yield: 9.68%
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise Sapacitabine, an orally available prodrug of CNDAC, which is a novel nucleoside analog. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
Volume
Today's last reported volume for Cyclacel Pharmaceuticals is 231, 12.5% below its average volume of 264.
Cyclacel Pharmaceuticals's last close was $7.56, 32.32% under its 52-week high of $11.17.
Cyclacel Pharmaceuticals's Stock Yearly Top and Bottom Value
Cyclacel Pharmaceuticals's stock is valued at $7.56 at 09:15 EST, way below its 52-week high of $11.17 and way higher than its 52-week low of $6.04.
Cyclacel Pharmaceuticals's Moving Average
Cyclacel Pharmaceuticals's worth is way above its 50-day moving average of $6.66 and under its 200-day moving average of $8.24.More news about Cyclacel Pharmaceuticals.
2. Blackrock Health Sciences Trust (BME) - Dividend Yield: 5.67%
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Volume
Today's last reported volume for Blackrock Health Sciences Trust is 33127, 4.61% above its average volume of 31667.
Blackrock Health Sciences Trust's last close was $45.05, 9.86% under its 52-week high of $49.98.
Blackrock Health Sciences Trust's Revenue
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 5.72M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Blackrock Health Sciences Trust's stock is considered to be oversold (<=20).
Blackrock Health Sciences Trust's Stock Yearly Top and Bottom Value
Blackrock Health Sciences Trust's stock is valued at $45.05 at 09:15 EST, below its 52-week high of $49.98 and above its 52-week low of $42.29.
Blackrock Health Sciences Trust's Moving Average
Blackrock Health Sciences Trust's worth is under its 50-day moving average of $46.52 and under its 200-day moving average of $47.72.More news about Blackrock Health Sciences Trust.
3. Autohome (ATHM) - Dividend Yield: 2.85%
Autohome Inc. operates as an online destination for automobile consumers in the People's Republic of China. The company, through its websites, autohome.com.cn and che168.com, and its mobile applications and mini apps, delivers interactive content and tools to automobile consumers. It provides media services, including automaker advertising services and regional marketing campaigns; and leads generation services comprising dealer subscription services, advertising services for individual dealers, and used automobile listing and other platform-based services. The company also offers Autohome Mall, an online transaction platform for users to review automotive-related information, purchase coupons offered by automakers for discounts, and make purchases to complete the transaction; data products; and online bidding platform for used automobiles, as well as collects commissions for facilitating transactions of auto-financing and insurance products on its platform. The company was formerly known as Sequel Limited and changed its name to Autohome Inc. in October 2011. Autohome Inc. was incorporated in 2008 and is headquartered in Beijing, the People's Republic of China.
Volume
Today's last reported volume for Autohome is 340072, 65.24% below its average volume of 978246.
Autohome's last close was $30.57, 78.31% under its 52-week high of $140.92.
Autohome's Sales
Autohome's sales growth is a negative 29.2% for the present quarter and a decline by 1.3% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 64.2% and a negative 53.8%, respectively.
Autohome's Revenue
Year-on-year quarterly revenue growth declined by 23.8%, now sitting on 8.03B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Autohome's stock is considered to be overbought (>=80).
Autohome's Stock Yearly Top and Bottom Value
Autohome's stock is valued at $30.57 at 09:15 EST, way below its 52-week high of $140.92 and way higher than its 52-week low of $26.10.
Autohome's Moving Average
Autohome's value is under its 50-day moving average of $31.92 and way below its 200-day moving average of $50.44.More news about Autohome.
4. Intel (INTC) - Dividend Yield: 2.75%
Intel Corporation designs, manufactures, and sells essential technologies for the cloud, smart, and connected devices worldwide. The company operates through DCG, IOTG, Mobileye, NSG, PSG, CCG, and All Other segments. It offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and non-platform or adjacent products comprising accelerators, boards and systems, connectivity products, and memory and storage products. The company also provides Internet of things products, including high-performance compute solutions for targeted verticals and embedded applications; and computer vision and machine learning-based sensing, data analysis, localization, mapping, and driving policy technology. It serves original equipment manufacturers, original design manufacturers, and cloud service providers. The company has collaborations with UC San Francisco's Center for Digital Health Innovation, Fortanix, and Microsoft Azure to establish a computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms. Intel Corporation was founded in 1968 and is headquartered in Santa Clara, California.
Volume
Today's last reported volume for Intel is 31125400, 13.6% below its average volume of 36026700.
Intel's last close was $48.01, 29.9% below its 52-week high of $68.49.
Intel's Sales
Intel's sales growth is a negative 0.5% for the current quarter and a decline by 8.6% for the next.
Intel's Revenue
Year-on-year quarterly revenue growth grew by 4.7%, now sitting on 78.47B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Intel's stock is considered to be overbought (>=80).
Intel's Stock Yearly Top and Bottom Value
Intel's stock is valued at $48.01 at 09:15 EST, way below its 52-week high of $68.49 and higher than its 52-week low of $45.24.
Intel's Moving Average
Intel's worth is below its 50-day moving average of $51.09 and way under its 200-day moving average of $55.75.More news about Intel.
5. Fidelity D & D Bancorp (FDBC) - Dividend Yield: 2.56%
Fidelity D & D Bancorp, Inc. operates as the bank holding company for The Fidelity Deposit and Discount Bank that provides a range of banking, trust, and financial services to individuals, small businesses, and corporate customers. The company accepts savings, clubs, interest-bearing and non-interest bearing checking, money market, and short- and long-term time deposits, as well as certificates of deposit. Its loan products include commercial and industrial loans, commercial real estate loans, consumer loans, and residential mortgage loans. The company also provides alternative financial and insurance products with asset management services. As of December 31, 2020, it operated 20 full-service banking offices in Lackawanna, Luzerne, Northampton, and Lehigh counties, Pennsylvania. Fidelity D & D Bancorp, Inc. was founded in 1902 and is headquartered in Dunmore, Pennsylvania.
Volume
Today's last reported volume for Fidelity D & D Bancorp is 191, 96.04% below its average volume of 4824.
Fidelity D & D Bancorp's last close was $51.50, 25.85% under its 52-week high of $69.45.
Fidelity D & D Bancorp's Revenue
Year-on-year quarterly revenue growth grew by 33.5%, now sitting on 78.12M for the twelve trailing months.
Fidelity D & D Bancorp's Stock Yearly Top and Bottom Value
Fidelity D & D Bancorp's stock is valued at $51.04 at 09:15 EST, way below its 52-week high of $69.45 and way above its 52-week low of $43.69.
Fidelity D & D Bancorp's Moving Average
Fidelity D & D Bancorp's value is below its 50-day moving average of $53.64 and below its 200-day moving average of $53.48.More news about Fidelity D & D Bancorp.